- Hisanori Umehara1,2),*,**,
- Akio Nakajima1),
- Takuji Nakamura1),
- Takafumi Kawanami1),
- Masao Tanaka1),
- Lingli Dong3) and
- Mitsuhiro Kawano4)
+Author Affiliations
- ↵* Corresponding author: Hisanori Umehara Contact email: umehara606@gmail.comDepartment of Clinical Immunology, Graduate School of Medicine and Faculty of Medicine, Kyoto University, Kawahara-cho 54 Shougoin, Sakyo-ku, Kyoto 606-8501, Japan, Tel: +81-75-751-4379, FAX: +81-75-751-4338
- ↵** Present address: Department of Clinical Immunology, Graduate School of Medicine and Faculty of Medicine, Kyoto University, Kyoto 606-8501
- Received October 26, 2013.
Abstract
IgG4-related disease (IgG4-RD) is a novel clinical entity proposed in Japan in the 21th century and is attracting strong attention over the world. The characteristic manifestations of IgG4-RD are elevated serum IgG4 concentration and tumefaction by IgG4-positive plasma cells. Although the clinical manifestations in various organs have been established, the pathogenesis of IgG4-RD is still unknown. Recently, many reports in aberrant acquired immunity such as Th2-diminated immune responses have been published. However, many questions still remain, including questions about the pathogenesis of IgG4-RD and the roles of IgG4. In this review, we discuss the pathogenesis of IgG4-RD by focusing on the crosstalk between innate and acquired immunity.
Key words
This Article
- Int. Immunol. (2014)doi: 10.1093/intimm/dxu074
- Full Text (PDF)Free
No comments:
Post a Comment